ARCHIVES

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Government Shutdown Cancels NCI Site Visit To Mayo Cancer Center

October 11, 2013

In Brief: 163 PIs Hold Both Contracts, Grants; Hopkins Scientists Questions Retrospective Diet Studies

August 27, 1976

How NCI Plans to Spend the $3 Billion Budget; But First, A Caveat From the Director

November 19, 1999

Celecoxib Effective To Prevent Colon Adenomas, Study Finds

April 25, 2008

Clearinghouse Opens With Predictable Controversy; Brown Urges ‘Open Minds’

November 12, 1976

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

June 7, 2002